Log in
Registration
Українська
English
Search for:
Home
Online Publication
Current Issue
Issue Archive
Authors
About
Information About the Journal
Focus and Scope
Indexing
For Authors
Submission Guidelines and Requirements
Peer Review
Article Processing Charges
Copyright and Licensing
Policies
Editorial Policy
Plagiarism Policy
Archiving Policy
Policy on the Use of Artificial Intelligence (AI) and AI-Supported Technologies
Open Access
Procedure for the Retraction of Published Articles
Ethical Issues
Publication Ethics
Procedure for Handling Complaints Regarding Ethical Breaches
Privacy Statement
International Standards and Principles of Operation
Organization of anticancer fight
Tumors of the chest cavity
Tumors of abdominal organs
Tumors of skin, soft tissues, bones
Breast tumor
Oncogynecology
Tumors of the head and neck
Oncurology
Oncohematology
Radiation diagnostics, radiation therapy
Experimental studies
Magazine online
All news
Peritoneal carcinomatosis from gastric cancer treatment perspectives. A narrative review
Authors: Pepenin M.O. Kondratskyi Y.M. Dobrzhanskyi O.Y. Kolesnyk A.V.... Т. 15, №2 (58)
Retrospective analysis of radical treatment of patients with stage III–IV larynpharyngetal cancer
Authors: Mykhailiuk P.I. Hirna H.A. Kostyshyn I.D. Tsybran S.S.... Т. 15, №2 (58)
Subscapular artery system flaps in head and neck reconstructive surgery: literature review and clinical experience
Authors: Fokin H.H. Kravets O.V. Т. 15, №1 (57)
Urachal carcinoma in the practice of a surgical oncologist: a clinical case series
Authors: Antoniv R.R. Pysar A.M. Т. 15, №1 (57)
Side effects of iodine-negative thyroid cancer targeted therapy
Authors: Solodyannikova O.I. Bankovska N.V. Danylenko V.V. Turitsyna V.L. Т. 15, №1 (57)
Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/−bevacizumab for the first-line treatment of non-squamous NSCLC: a matching-adjusted indirect comparison
Т. 15, №1 (57)
Pembrolizumab plus chemotherapy for metastatic NSCLC with programmed cell death ligand 1 tumor proportion score <1%: pooled analysis of outcomes after five years of follow-up
Т. 15, №1 (57)
Thromboprophylaxis with original enoxaparin in oncology patients
Т. 15, №1 (57)
Inferior vena cava resection and reconstruction with falciform ligament graft for leiomyosarcoma. Case report
Authors: Kvasivka O.O. Moiseienko A.B. Pareniuk R.Y. Pepenin I.O.... Т. 15, №1 (57)
Reconstruction of the mandible using CAD/CAM technologies in patients with oral cancer and primary bone tumors
Author:Burtyn O.V. Т. 15, №1 (57)
CLL in the context of evidence-based medicine: how do international guidelines align with Ukrainian practice?
Authors: Kryachok I.A. Tytorenko I.B. Moroz Y.V. Т. 14, №4 (56)
Midazolam in modern anesthesiology and intensive care
Authors: Lisnyy I.I. Zakalska K.A. Т. 14, №4 (56)
Conducting mobilization courses and apheresis of CD34
+
. Experience of the Nonprofit Organization National Cancer Institute
Authors: Kryachok I.A. Raіnyk K.P. Shokun N.V. Burtna A.S. Т. 14, №4 (56)
Pembrolizumab
vs
Placebo as Adjuvant Therapy for High-Risk Stage II Melanoma: Long-Term Follow-Up, Rechallenge, and Crossover in KEYNOTE-716
Т. 14, №4 (56)
Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial
Т. 14, №4 (56)
« Первая
«
...
3
4
5
6
7
...
10
20
30
...
»
Последняя »